Glutamate for Metabolic Intervention in Coronary Surgery
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether intravenous glutamate infusion given
in association with surgery for unstable coronary artery disease can protect the heart from
myocardial injury, postoperative heart failure and death.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Linkoeping
Collaborators:
Blekingesjukhuset, Karlskrona Region Örebro County